ArticleFrontiers in pharmacology2021
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 45 citations in OpenAlex.
- Exploration on appropriate brewing conditions ofFood chemistry: X · 2026Article
- Mechanistic insights into taste modulation ofFood chemistry: X · 2026Article
- Article
- Evaluation ofFood chemistry: X · 2026Article
- Metabolomics analysis reveals kernel quality variation among main yellowhorn (Xanthoceras sorbifolium Bunge) cultivars.BMC plant biology · 2026Article
- Genome-wide characterization and expression pattern analysis ofPlant signaling & behavior · 2025Article
- Study on the mechanism ofAnnals of medicine · 2025Article
- LeafRSC advances · 2025Article
- Additions to Pleosporalean Taxa Associated withMicroorganisms · 2025Article
- Genome-wide characterization of FAD gene family in Xanthoceras sorbifolium Bunge and germplasm assessment.PloS one · 2025Article
- Virtual screening and molecular dynamics of anti-Alzheimer compounds fromFrontiers in chemistry · 2025Article
- Genome-Wide Characterization and Development of Simple Sequence Repeat Markers for Molecular Diversity Analyses in Yellowhorn (Plants (Basel, Switzerland) · 2024Article
- The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment.Metabolites · 2024Review
- Widely Targeted Metabolomics and Network Pharmacology Reveal the Nutritional Potential of Yellowhorn (Foods (Basel, Switzerland) · 2024Article
- Agronomic, physiological and transcriptional characteristics provide insights into fatty acid biosynthesis in yellowhorn (Frontiers in genetics · 2024Article
- Metabolomics analysis reveals amelioration effects of yellowhorn tea extract on hyperlipidemia, inflammation, and oxidative stress in high-fat diet-fed mice.Frontiers in nutrition · 2023Article
- Editorial: Woody oil crops: key trait formation and regulation.Frontiers in plant science · 2023Article
- Loureirin C and Xanthoceraside Prevent Abnormal Behaviors Associated with Downregulation of Brain Derived Neurotrophic Factor and AKT/mTOR/CREB Signaling in the Prefrontal Cortex Induced by Chronic Corticosterone Exposure in Mice.Neurochemical research · 2022Article
- Influence of planting yellowhorn (PeerJ · 2022Article
- GC/MS-Based Urine Metabolomics Study on the Ameliorative Effect ofEvidence-based complementary and alternative medicine : eCAM · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.